INNOVA CAPTAB
Quarterly Results Analysis [Dec2024]
INNOVA CAPTAB Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹316 Cr | ₹318 Cr | ₹294 Cr | ₹263 Cr | ₹302 Cr | ₹283 Cr | ₹233 Cr | ₹241 Cr |
Expenses | ₹270 Cr | ₹268 Cr | ₹252 Cr | ₹225 Cr | ₹258 Cr | ₹242 Cr | ₹202 Cr | ₹214 Cr |
Operating Income | ₹47 Cr | ₹50 Cr | ₹42 Cr | ₹38 Cr | ₹45 Cr | ₹40 Cr | ₹31 Cr | ₹27 Cr |
Other Income | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹7 Cr | ₹9 Cr | ₹5 Cr | ₹5 Cr |
Depreciation | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹46 Cr | ₹47 Cr | ₹39 Cr | ₹40 Cr | ₹35 Cr | ₹30 Cr | ₹25 Cr | ₹21 Cr |
Profit After Tax | ₹34 Cr | ₹35 Cr | ₹29 Cr | ₹29 Cr | ₹25 Cr | ₹23 Cr | ₹18 Cr | ₹17 Cr |
EPS | ₹5.98 | ₹6.12 | ₹5.15 | ₹5.02 | ₹4.39 | ₹4.77 | ₹3.67 | ₹3.59 |
Industry Peers & Returns | 1W | 1M | 1Y |
INNOVA CAPTAB | -0.4% | 27.2% | 95.7% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
INNOVA CAPTAB Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -0.55 % |
Y-o-Y | 4.62 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹316 Cr | -0.55 | |
Sep2024 | ₹318 Cr | 8.13 | |
Jun2024 | ₹294 Cr | 12.05 | |
Mar2024 | ₹263 Cr | -13.17 | |
Dec2023 | ₹302 Cr | 6.91 | |
Sep2023 | ₹283 Cr | 21.31 | |
Jun2023 | ₹233 Cr | -3.20 | |
Mar2023 | ₹241 Cr | - |
INNOVA CAPTAB Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -6.38 % |
Y-o-Y | 4.40 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹47 Cr | -6.38 | |
Sep2024 | ₹50 Cr | 17.92 | |
Jun2024 | ₹42 Cr | 10.76 | |
Mar2024 | ₹38 Cr | -14.62 | |
Dec2023 | ₹45 Cr | 10.18 | |
Sep2023 | ₹40 Cr | 29.33 | |
Jun2023 | ₹31 Cr | 16.80 | |
Mar2023 | ₹27 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -5.89 % |
Y-o-Y | -0.20 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 14.71% | -5.89 | |
Sep2024 | 15.63% | 9.07 | |
Jun2024 | 14.33% | -1.17 | |
Mar2024 | 14.5% | -1.63 | |
Dec2023 | 14.74% | 3.00 | |
Sep2023 | 14.31% | 6.63 | |
Jun2023 | 13.42% | 20.68 | |
Mar2023 | 11.12% | - |
INNOVA CAPTAB Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -2.29 % |
Y-o-Y | 36.13 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹34 Cr | -2.29 | |
Sep2024 | ₹35 Cr | 18.75 | |
Jun2024 | ₹29 Cr | 2.63 | |
Mar2024 | ₹29 Cr | 14.31 | |
Dec2023 | ₹25 Cr | 9.70 | |
Sep2023 | ₹23 Cr | 30.19 | |
Jun2023 | ₹18 Cr | 1.96 | |
Mar2023 | ₹17 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -1.73 % |
Y-o-Y | 30.08 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 10.81 % | -1.73 | |
Sep2024 | 11 % | 9.78 | |
Jun2024 | 10.02 % | -8.41 | |
Mar2024 | 10.94 % | 31.65 | |
Dec2023 | 8.31 % | 2.59 | |
Sep2023 | 8.1 % | 7.43 | |
Jun2023 | 7.54 % | 5.31 | |
Mar2023 | 7.16 % | - |
INNOVA CAPTAB Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -2.29 % |
Y-o-Y | 36.22 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹5.98 | -2.29 | |
Sep2024 | ₹6.12 | 18.83 | |
Jun2024 | ₹5.15 | 2.59 | |
Mar2024 | ₹5.02 | 14.35 | |
Dec2023 | ₹4.39 | -7.97 | |
Sep2023 | ₹4.77 | 29.97 | |
Jun2023 | ₹3.67 | 2.23 | |
Mar2023 | ₹3.59 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD